6,678 trials
Erectile Dysfunction
Primary: Percentage of Participants Experiencing at Least One Treatment Emergent Adverse Event (Serious or Non-Serious) — 33.8; 35.9 Percentage of participants
Diabetes Mellitus, Type 2
Primary: HbA1c Change — -0.42; -0.58; -1.04; -1.59 absolute change in %HbA1c
Major Depressive Disorder · Healthy Controls
Primary: Money Earned — 23.2; 25.0; 20.5; 21.9 US Dollars
Rosacea
Primary: Pre-Treatment Clinician Erythema Assessment (CEA) — 0; 0; 7; 144 Participants
Rosacea
Primary: Efficacy Variable: Percentage of Patients Defined as Success on the Global Rosacea Severity Grading Scale Called Investigator's Global Assessment (IGA): — 53; 35…
Hepatitis C, Chronic
Primary: Treatment Efficacy — 10; 51; 0 Participants
Healthy Volunteers
Primary: Maximum Effect of ADASUVE on Cardiac Repolarization (QTc Interval Duration) at the Maximum Clinical Dose Compared to Placebo — 4.04 msec
Depression · Mild Cognitive Impairment
Primary: Selective Reminding Test (SRT) Total Recall — 45.6; 46.6 Words
Hypertension, Pulmonary
Primary: Change From Baseline in Medical Outcomes Study Short Form 36 (SF-36) — -1.156; -0.765; 0.002; 0.781 Score on a scale
Pain
Primary: Cumulative Narcotic Consumption — 19; 14 Participants
Ulcerative Colitis
Primary: Percentage of Participants Meeting Partial Mayo Score Response Criteria Through Week 54 — 24.9 Percentage of Participants
Asthma
Primary: Maximal Percent Decrease in Forced Expiratory Volume in One Second (FEV1) Following Exercise Challenge at 12 Hours (Hrs) Post Evening Dose From Pre-exercise FEV1…
Hot Flashes
Primary: Cognitive Function as Assessed by the National Adult Reading Test (NART) — 45.2; 39.6; 42.43; 41.29 units on a scale
Neuromuscular Blockade · Surgery · Anesthesia
Primary: Mean Value of Peak Inspiratory Pressure — 18.4; 20.2 cmH2O — p=<0.001
Hypertension, Pulmonary
Primary: Change From Baseline to Week 24 in the Living With Pulmonary Hypertension (LPH) Questionnaire Total Score — -10.99 Scores